Literature DB >> 9541584

Activation of caspase-3-like enzymes in non-apoptotic T cells.

S Wilhelm1, H Wagner, G Häcker.   

Abstract

The activation of the caspase family of cysteine proteases is a key step in the implementation of apoptotic cell death leading to further downstream effects such as DNA fragmentation. In cultured tumor cells, caspase activity appears only when cells are undergoing apoptosis. Here we show that human and murine T lymphocytes acquire high intracellular activities of cell death-specific caspases upon activation by mitogens and IL-2 without evidence that apoptosis is proceeding. The highest activity is seen when cells are mitogen activated for 3 days. On a per cell basis, caspase activity in activated T cells is much higher than in tumor cells induced to undergo apoptosis. In the presence of exogenously added IL-2 cells stay alive and maintain a high level of caspase activity while IL-2 withdrawal results in cell death and decline of caspase activity. Caspase activity can also be measured in extracts from spleen and lymph nodes from mice injected with superantigen. While in tumor cell lines caspase activity correlates with cleavage of poly(ADP)-ribose polymerase (PARP) and DNA fragmentation, in activated T cells cleavage products of cellular PARP can be detected whereas DNA fragmenting activity appears only upon IL-2 withdrawal which coincides with cell death. These data show that caspase activation in intact cells does not necessarily lead to cell death and argue for a checkpoint in the apoptotic pathway downstream of caspases. Furthermore, they provide a molecular correlate for the high susceptibility of activated T cells for apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541584     DOI: 10.1002/(SICI)1521-4141(199803)28:03<891::AID-IMMU891>3.0.CO;2-X

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Authors:  Nobuyoshi Hanaoka; Bana Jabri; Zhenpeng Dai; Cezary Ciszewski; Anne M Stevens; Cassian Yee; Hideki Nakakuma; Thomas Spies; Veronika Groh
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

2.  Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells.

Authors:  Heidi Högel; Krista Rantanen; Terhi Jokilehto; Reidar Grenman; Panu M Jaakkola
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

3.  Caspases and nitric oxide broadly regulate dendritic cell maturation and surface expression of class II MHC proteins.

Authors:  Siew Heng Wong; Laura Santambrogio; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-14       Impact factor: 11.205

Review 4.  Death receptors and caspases: role in lymphocyte proliferation, cell death, and autoimmunity.

Authors:  Sabine Adam-Klages; Dieter Adam; Ottmar Janssen; Dieter Kabelitz
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Chrysophanol, an anthraquinone from AST2017-01, possesses the anti-proliferative effect through increasing p53 protein levels in human mast cells.

Authors:  Na-Ra Han; Hee-Yun Kim; Soonsik Kang; Mi Hye Kim; Kyoung Wan Yoon; Phil-Dong Moon; Hyung-Min Kim; Hyun-Ja Jeong
Journal:  Inflamm Res       Date:  2019-05-04       Impact factor: 4.575

6.  Kinetics of T lymphocyte apoptosis and the cellular immune response in SIVmac239-infected rhesus macaques.

Authors:  Mareike Meythaler; Sarah Pryputniewicz; Amitinder Kaur
Journal:  J Med Primatol       Date:  2008-12       Impact factor: 0.667

7.  Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytes.

Authors:  Mayte Coiras; María Rosa López-Huertas; Elena Mateos; José Alcamí
Journal:  Retrovirology       Date:  2008-12-01       Impact factor: 4.602

8.  Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein.

Authors:  Cristina Aresté; Mohamed Mutocheluh; David J Blackbourn
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

9.  Dose-dependent lymphocyte apoptosis following respiratory infection with Vaccinia virus.

Authors:  Nicole L Yates; Rama D Yammani; Martha A Alexander-Miller
Journal:  Virus Res       Date:  2008-08-23       Impact factor: 3.303

10.  Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis.

Authors:  H Stridh; A Planck; D Gigliotti; A Eklund; J Grunewald
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.